TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis.
about
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastomaAntitumor Activity of a 5-Hydroxy-1H-Pyrrol-2-(5H)-One-Based Synthetic Small Molecule In Vitro and In VivoRAIN-Droplet: a novel 3D in vitro angiogenesis modelMetronomic small molecule inhibitor of Bcl-2 (TW-37) is antiangiogenic and potentiates the antitumor effect of ionizing radiationSmall-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells.Endothelium Expression of Bcl-2 Is Essential for Normal and Pathological Ocular Vascularization.Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review.Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effectsA phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer.The La protein counteracts cisplatin-induced cell death by stimulating protein synthesis of anti-apoptotic factor Bcl2.Small-molecule inhibitors reveal a new function for Bcl-2 as a proangiogenic signaling molecule.A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia.Targeting cancer cell mitochondria as a therapeutic approach: recent updates.A NOXA/MCL-1 Imbalance Underlies Chemoresistance of Malignant Rhabdoid Tumor Cells.Alternol induces an S-phase arrest of melanoma B16F0 cells.Synergistic combination of small molecule inhibitor and RNA interference against antiapoptotic Bcl-2 protein in head and neck cancer cells.Alteronol inhibits proliferation in HeLa cells through inducing a G1-phase arrest.SHED differentiate into functional odontoblasts and endothelium.The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells.MCL-1 inhibition in cancer treatment
P2860
Q26827928-9153470C-AF1E-464C-BCA3-D876932430B9Q28547861-A62E0869-BD96-49E2-BB82-1EF4C05DA53AQ30579854-1BC1017B-4387-4750-9766-CE254A729F00Q34158974-0217CB0D-3761-4E81-9C76-777DFC9E8B90Q35154341-191A65D5-1139-42DF-A502-6DB546620F45Q36211402-6D568B1F-71C9-4E54-8D63-319D48F2FD04Q36356086-0EDC4553-76AF-483C-BE3B-5D8469E5F8AAQ36541458-195F4836-3038-4B17-AA87-B6AB37E8B5F6Q37109324-E1FC30D0-34EC-49A5-8B1D-1AEDE7B1B912Q37284056-24846B2E-C276-4470-8164-65C8F6753D0FQ37301910-AF6B97D7-6BD1-4DDE-9FE8-878E50A5F297Q37799747-8D72E15B-5D6D-46A5-AB9A-63F5B5027558Q38061861-AC30881D-43EC-489F-AD56-BE1670F919D3Q38668524-DB14BDC7-1B86-435E-A22E-C70E429CC09FQ38810868-16704BE2-71EE-401C-8A7C-4CAE255D3D3DQ39041954-76D4D97C-B83B-4302-B6A1-320D43C1143CQ39144121-31C31BBB-E503-4760-AB88-79B882918661Q39431620-E886CC55-41C0-410E-B190-652D775EEAA8Q43097911-30FD728B-3792-44AF-8E8F-852C69F78924Q43116731-376C0C9B-201F-4E4A-A46F-AB72CEECEE73Q44448455-204D6B46-00CF-414C-8099-2C5573285118Q58694408-88D311DF-D220-431E-A752-3E622336313B
P2860
TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
TW-37, a small-molecule inhibi ...... d and neck tumor angiogenesis.
@en
type
label
TW-37, a small-molecule inhibi ...... d and neck tumor angiogenesis.
@en
prefLabel
TW-37, a small-molecule inhibi ...... d and neck tumor angiogenesis.
@en
P2093
P2860
P1476
TW-37, a small-molecule inhibi ...... d and neck tumor angiogenesis.
@en
P2093
Aaron C Spalding
Benjamin D Zeitlin
Ilan M Turkienicz
Jacques E Nör
Kristy Warner
Naoki Ashimori
Shaomeng Wang
Theodoros N Teknos
Zhaocheng Zhang
P2860
P304
P356
10.1158/1535-7163.MCT-08-1078
P577
2009-04-01T00:00:00Z